Arkolith/Insider Trading/PTGX/Form 4

Waddill William D.

DirectorProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Oct 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$979K
Net Open-Market Flow
-$979K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 10, 2025Sell(S)8K$87.81$702K5K
Oct 10, 2025Option exercise(M)12K$6.98$84K17K
Oct 10, 2025Sell(S)4K$69.25$277K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 10, 2025Option exercise(M)12K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-099252) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML